[The immunosuppressive agents in rheumatology. Indications, results and problems of long-term surveillance].
D000328:Adult; D000368:Aged; D000477:Alkylating Agents / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use; D003095:Collagen Diseases / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007938:Leukemia / Q000139:chemically induced; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000139:chemically induced; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012213:Rheumatic Fever / Q000188:drug therapy; D013997:Time Factors
D000477:Alkylating Agents; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D001379:Azathioprine
Les immunodépresseurs en rhumatologie. Indications, résultats et problèmes de surveillance à long terme